Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Hepatic ADC value correlates with cirrhotic severity of patients with biliary atresia.

Mo YH, Jaw FS, Ho MC, Wang YC, Peng SS.

Eur J Radiol. 2011 Dec;80(3):e253-7. doi: 10.1016/j.ejrad.2010.11.002. Epub 2010 Nov 30.

PMID:
21123015
2.

Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients.

Peng SS, Jeng YM, Hsu WM, Yang JC, Ho MC.

Eur Radiol. 2015 Oct;25(10):2992-3002. doi: 10.1007/s00330-015-3716-1. Epub 2015 Apr 29.

PMID:
25921590
3.

[Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].

Zhou ML, Yan FH, Xu PJ, Chen CZ, Shen JZ, Li RC, Ji Y, Shi JY.

Zhonghua Yi Xue Za Zhi. 2009 Jul 7;89(25):1757-61. Chinese.

PMID:
19862980
4.
5.

Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.

Taouli B, Tolia AJ, Losada M, Babb JS, Chan ES, Bannan MA, Tobias H.

AJR Am J Roentgenol. 2007 Oct;189(4):799-806.

PMID:
17885048
6.

Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?

Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK.

Aliment Pharmacol Ther. 2005 Dec;22(11-12):1079-89. Review.

7.

Serum insulinlike growth factor-1 and its binding protein-3 levels in children with cirrhosis waiting for a liver transplant.

Dehghani SM, Karamifar H, Hamzavi SS, Haghighat M, Malek-Hosseini SA.

Exp Clin Transplant. 2012 Jun;10(3):252-7.

8.

Diffusion-weighted magnetic resonance imaging for characterization of focal liver masses: impact of parallel imaging (SENSE) and b value.

Erturk SM, Ichikawa T, Sano K, Motosugi U, Sou H, Araki T.

J Comput Assist Tomogr. 2008 Nov-Dec;32(6):865-71. doi: 10.1097/RCT.0b013e3181591cf2.

PMID:
19204445
9.

Reproducibility of measurement of apparent diffusion coefficients of malignant hepatic tumors: effect of DWI techniques and calculation methods.

Kim SY, Lee SS, Park B, Kim N, Kim JK, Park SH, Byun JH, Song KJ, Koo JH, Choi EK, Lee MG.

J Magn Reson Imaging. 2012 Nov;36(5):1131-8. doi: 10.1002/jmri.23744. Epub 2012 Jul 6.

PMID:
22777895
10.

Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis.

Koinuma M, Ohashi I, Hanafusa K, Shibuya H.

J Magn Reson Imaging. 2005 Jul;22(1):80-5.

PMID:
15971188
11.

Diffusion-weighted magnetic resonance imaging of the liver in hepatitis B patients with Child-Pugh a cirrhosis.

Hsu FO, Chiou YY, Chen CY, Liu GC, Chu HC, Liu HC, Chu HM, Hsu JS.

Kaohsiung J Med Sci. 2007 Sep;23(9):442-6.

12.

Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.

Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.

J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671.

PMID:
20657216
13.

The effect of liver iron deposition on hepatic apparent diffusion coefficient values in cirrhosis.

Chandarana H, Do RK, Mussi TC, Jensen JH, Hajdu CH, Babb JS, Taouli B.

AJR Am J Roentgenol. 2012 Oct;199(4):803-8.

PMID:
22997371
14.

The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.

Oka K, Yakushiji T, Sato H, Hirai T, Yamashita Y, Mizuta H.

Skeletal Radiol. 2010 Feb;39(2):141-6. doi: 10.1007/s00256-009-0830-7. Epub 2009 Nov 19.

PMID:
19924412
15.

Comparison between two-point and four-point methods for quantification of apparent diffusion coefficient of normal liver parenchyma and focal lesions. Value of normalization with spleen.

Papanikolaou N, Gourtsoyianni S, Yarmenitis S, Maris T, Gourtsoyiannis N.

Eur J Radiol. 2010 Feb;73(2):305-9. doi: 10.1016/j.ejrad.2008.10.023. Epub 2008 Dec 16.

PMID:
19091503
16.

Hepatic hemangioma: correlation of enhancement types with diffusion-weighted MR findings and apparent diffusion coefficients.

Goshima S, Kanematsu M, Kondo H, Yokoyama R, Kajita K, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.

Eur J Radiol. 2009 May;70(2):325-30. doi: 10.1016/j.ejrad.2008.01.035. Epub 2008 Mar 5.

PMID:
18321673
17.

Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.

Choi PC, Kim HJ, Choi WH, Park DI, Park JH, Cho YK, Sohn CI, Jeon WK, Kim BI.

Liver Int. 2009 Feb;29(2):221-6. doi: 10.1111/j.1478-3231.2008.01803.x. Epub 2008 Jun 9.

PMID:
18544124
18.

[Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results].

Aubé C, Racineux PX, Lebigot J, Oberti F, Croquet V, Argaud C, Calès P, Caron C.

J Radiol. 2004 Mar;85(3):301-6. French.

19.

Liver lobe-based magnetic resonance diffusion-weighted imaging using multiple b values in patients with hepatitis B-related liver cirrhosis: association with the liver disease severity according to the Child-Pugh class.

Tang HJ, Zhou L, Zhang XM, Liu J, Chen TW, Zeng NL, Wang D, Li J, Huang YC, Tang YL, Hu J.

Clinics (Sao Paulo). 2015 Jul;70(7):486-92. doi: 10.6061/clinics/2015(07)05. Epub 2015 Jul 1.

20.

Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ.

Do RK, Chandarana H, Felker E, Hajdu CH, Babb JS, Kim D, Taouli B.

AJR Am J Roentgenol. 2010 Sep;195(3):671-6. doi: 10.2214/AJR.09.3448. Erratum in: AJR Am J Roentgenol. 2010 Oct;195(4):1043. Chandanara, Hersh [corrected to Chandarana, Hersh].

PMID:
20729445
Items per page

Supplemental Content

Write to the Help Desk